Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Therapeutics (CMPX) Prepaid Assets (2023 - 2025)

Compass Therapeutics' Prepaid Assets history spans 3 years, with the latest figure at $913000.0 for Q4 2025.

  • For Q4 2025, Prepaid Assets fell 84.86% year-over-year to $913000.0; the TTM value through Dec 2025 reached $913000.0, down 84.86%, while the annual FY2025 figure was $913000.0, 84.86% down from the prior year.
  • Prepaid Assets for Q4 2025 was $913000.0 at Compass Therapeutics, down from $1.2 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $11.5 million in Q1 2025 and bottomed at $913000.0 in Q4 2025.
  • The 3-year median for Prepaid Assets is $5.5 million (2024), against an average of $5.0 million.
  • The largest YoY upside for Prepaid Assets was 388.54% in 2025 against a maximum downside of 84.86% in 2025.
  • A 3-year view of Prepaid Assets shows it stood at $1.4 million in 2023, then surged by 324.58% to $6.0 million in 2024, then crashed by 84.86% to $913000.0 in 2025.
  • Per Business Quant, the three most recent readings for CMPX's Prepaid Assets are $913000.0 (Q4 2025), $1.2 million (Q3 2025), and $5.2 million (Q2 2025).